SLDB Executives Sell Shares at $6.44/Share Amid Ongoing Challenges

Solid Biosciences Inc. (SLDB) has disclosed that several high-ranking officials have recently sold shares of the company. On February 4, 2026, Chief Medical Officer Brooks Gabriel sold 12,616 shares at $6.44 per share, while Director, President and CEO Cumbo Alexander sold 48,913 shares at the same price. Director Ganot Ilan also sold 7,205 shares, and Chief Regulatory Officer Hanrahan Jessie sold 12,348 shares. Additionally, Chief Technology Officer Herzich Paul sold 10,905 shares, Chief Operating Officer Howton David T sold 18,894 shares, and CFO & Treasurer Tan Kevin sold 14,783 shares.